IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 28 filers reported holding IMMUCELL CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,698 | +13.8% | 12,865 | +6.5% | 0.00% | – |
| Q2 2023 | $60,385 | -4.8% | 12,077 | -2.7% | 0.00% | – |
| Q1 2023 | $63,445 | -16.4% | 12,416 | -0.2% | 0.00% | – |
| Q4 2022 | $75,914 | -20.1% | 12,445 | -1.8% | 0.00% | – |
| Q3 2022 | $95,000 | -13.6% | 12,667 | +0.3% | 0.00% | – |
| Q2 2022 | $110,000 | -14.1% | 12,633 | -5.2% | 0.00% | – |
| Q1 2022 | $128,000 | +20.8% | 13,325 | +0.4% | 0.00% | – |
| Q4 2021 | $106,000 | -16.5% | 13,275 | -1.7% | 0.00% | – |
| Q3 2021 | $127,000 | -0.8% | 13,503 | +0.3% | 0.00% | – |
| Q2 2021 | $128,000 | -1.5% | 13,465 | 0.0% | 0.00% | – |
| Q1 2021 | $130,000 | +71.1% | 13,465 | +4.7% | 0.00% | – |
| Q4 2020 | $76,000 | +20.6% | 12,865 | +11.0% | 0.00% | – |
| Q3 2020 | $63,000 | 0.0% | 11,594 | -13.6% | 0.00% | – |
| Q2 2020 | $63,000 | +28.6% | 13,413 | +3.4% | 0.00% | – |
| Q1 2020 | $49,000 | -43.7% | 12,966 | +24.2% | 0.00% | – |
| Q3 2018 | $87,000 | +22.5% | 10,443 | 0.0% | 0.00% | – |
| Q2 2018 | $71,000 | – | 10,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 101,594 | $542,502 | 0.13% |
| PERRITT CAPITAL MANAGEMENT INC | 27,026 | $144,319 | 0.08% |
| WEALTH EFFECTS LLC | 15,617 | $83,393 | 0.04% |
| Overbrook Management Corp | 32,857 | $175,453 | 0.04% |
| Prosperity Planning, Inc. | 16,000 | $85,438 | 0.04% |
| SHUFRO ROSE & CO LLC | 62,408 | $333,253 | 0.03% |
| Strategic Financial Services, Inc, | 31,000 | $159,960 | 0.01% |
| Essex Financial Services, Inc. | 11,000 | $58,739 | 0.01% |
| HEADINVEST, LLC | 3,118 | $16,338 | 0.00% |
| Cresset Asset Management, LLC | 103,606 | $534,607 | 0.00% |